Cargando…
Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson’s Disease
Parkinson’s disease (PD) is a degenerative disease that affects approximately 6.1 million people and is primarily caused by the loss of dopaminergic neurons. Naphthoquinones have several biological activities explored in the literature, including neuroprotective effects. Therefore, this review shows...
Autores principales: | Santos, Thaís Barreto, de Moraes, Leonardo Gomes Cavalieri, Pacheco, Paulo Anastácio Furtado, dos Santos, Douglas Galdino, Ribeiro, Rafaella Machado de Assis Cabral, Moreira, Caroline dos Santos, da Rocha, David Rodrigues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674926/ https://www.ncbi.nlm.nih.gov/pubmed/38004442 http://dx.doi.org/10.3390/ph16111577 |
Ejemplares similares
-
Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against Trypanosoma cruzi
por: Lara, Leonardo S., et al.
Publicado: (2021) -
Sesquiterpene Lactones: Promising Natural Compounds to Fight Inflammation
por: Matos, Melanie S., et al.
Publicado: (2021) -
Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors
por: Pacheco, Paulo Anastácio Furtado, et al.
Publicado: (2023) -
Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis
por: Pereira, Eliezer Menezes, et al.
Publicado: (2006) -
Vasorelaxation Induced by a New Naphthoquinone-Oxime is Mediated by NO-sGC-cGMP Pathway
por: Dantas, Bruna P. V., et al.
Publicado: (2014)